Jorge Mendoza to Receptors, Tumor Necrosis Factor, Type II
This is a "connection" page, showing publications Jorge Mendoza has written about Receptors, Tumor Necrosis Factor, Type II.
Connection Strength
0.108
-
Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximab. Hum Immunol. 2014 Jan; 75(1):71-5.
Score: 0.108